Although this slump was obviously disappointing, the Medical company has seen 3 positive revisions and its current year loss consensus has narrowed over the past few weeks. This suggests that the recent slump might be a temporary blip on the radar for DRYS. So make sure to keep an eye on this stock going forward to see if yesterday’s price decline is confirmed by more weakness, or if it can rebound in the weeks ahead.
PRTA currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Some better-ranked stocks in the Medical and Biomedical industry include ANI Pharmaceuticals, Inc. (ANIP), Biogen Idec Inc. (BIIB) and Affymetrix Inc. (AFFX). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment